| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/08/2007 | CN101011544A Gout rapid recovery pill(capsule) and preparation technique thereof |
| 08/08/2007 | CN101011535A Pill for nourishing blood, reinforcing body fluid, nourishing blood and diapelling arthralgia and its preparation |
| 08/08/2007 | CN101011517A Liniment for treating arthralgia syndrome and preparing process thereof |
| 08/08/2007 | CN101011515A Traditional Chinese medicine composition for treating traumatic injury and bone fracture |
| 08/08/2007 | CN101011514A Chinese traditional medicine for treating osteonosus |
| 08/08/2007 | CN101011513A Pharmaceutical composition for treating bone fracture and its preparation |
| 08/08/2007 | CN101011511A Externally applied medicament for treating soft tissue injury |
| 08/08/2007 | CN101011510A Cervical-lumbar vertebrae pain dispelling liquid |
| 08/08/2007 | CN101011505A Externally used medicament for treating osteoarthrosis and preparation method thereof |
| 08/08/2007 | CN101011504A Chinese medicinal electuary for treating ankylosing spondylitis |
| 08/08/2007 | CN101011475A Externally used Chinese traditional medicine for treating osteonosus |
| 08/08/2007 | CN101011463A Use of perilla oil in the preparation of medicament preparation for preventing and treating osteoporosis and skin senescence |
| 08/08/2007 | CN101011448A Traditional Chinese medicine capsule for treating aseptic necrosis of femur head |
| 08/08/2007 | CN101011418A Granule for treating hyperosteogeny and preparation method thereof |
| 08/08/2007 | CN101011207A Health care medicated pillow |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/02/2007 | WO2007087585A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086565A1 Growth hormone secretion regulator |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086504A1 Carboxylic acid compound and use thereof |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007085205A1 Pyrrole substituted 2-indolinone derivatives, the preparation methods and medical uses thereof |
| 08/02/2007 | WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
| 08/02/2007 | WO2007061924A3 Methods of treating cartilage defects |
| 08/02/2007 | WO2007045927A3 Therapeutic agent |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178082 Stabilized single domain antibodies |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 08/01/2007 | EP1812451A2 Compounds and methods of use thereof |
| 08/01/2007 | EP1812418A1 Dibenzosuberone derivatives |
| 08/01/2007 | EP1812021A2 Once a day formulation for phosphate binders |
| 08/01/2007 | EP1811982A1 Therapeutic treatment of accelerated bone resorption |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | CN1329392C Substituted pyrazoles |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329374C Compound as CCR5 agonist |
| 08/01/2007 | CN1329077C Protein preparation for enhancing sclerotin and its preparation method |
| 08/01/2007 | CN1329076C Plaster for orthopaedics and its preparation method |
| 08/01/2007 | CN1329074C Pandanguo medicated liquor |
| 08/01/2007 | CN1329064C Copper battledore medicated liquor |
| 08/01/2007 | CN1329063C Medicated liquor of stephania japonica miers |
| 08/01/2007 | CN1329062C Method for preparing medicine for treating cataclasis and soft tissue injury |
| 08/01/2007 | CN1329058C Medicated liquor of cortex Zanthoxyli podocarpi |
| 08/01/2007 | CN1329057C Medicated liqor of Radix Oenotherae Erythrosepalae |
| 08/01/2007 | CN1329055C Mantuoluozi medicinal liquor |
| 08/01/2007 | CN1329054C Lopseed-root medicated liquor |
| 08/01/2007 | CN1329052C Medicated lanceolarium Roxb medicated liquor |
| 08/01/2007 | CN1329051C Luoshiteng medicated liquor |
| 08/01/2007 | CN1329048C Compound lotus plumule oral liquor |
| 08/01/2007 | CN1329046C Daoshenglian medicated liquor |
| 08/01/2007 | CN101010300A 2-phenylpyridine derivative |
| 08/01/2007 | CN101010087A High yield and rapid synthesis method for processing organic metal salt |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007176A Drug for treating rheumatoid, rheumatic and other bone and joint diseases |
| 08/01/2007 | CN101007162A Medicine bag containing traditional Chinese medicine for physiotherapy |
| 08/01/2007 | CN101007160A Plaster for treating ostealgia and its preparation method |
| 08/01/2007 | CN101007144A Traditional Chinese medicine for treating lumbago and leg pain induced by spine originated retrograde affection and preparation method |
| 08/01/2007 | CN101007128A Powder and salve for hyperplasia protrusion rehabilitation and its preparation method |
| 08/01/2007 | CN101007118A Application of 'Gu Kang' medicine in preparation of formulations for treating meridian stasis |
| 08/01/2007 | CN101007117A Application of 'Gu Kang' medicine in preparation of formulations for treating osteoarthritis and osteoporosis |
| 08/01/2007 | CN101007111A An externally appplied medicine for treating rheumatic diseases |
| 08/01/2007 | CN101007070A Prescription for treating rheumatic or rheumatoid diseases and traumatic injury |
| 08/01/2007 | CN101007061A Dampness-eliminating and pain-relieving medicinal liquor of Ramulus et Folium |
| 08/01/2007 | CN101007040A External applied medicine for treating fractures |
| 08/01/2007 | CN101007020A Composition of a cartilage protein and its application in medical treatment and health protection |
| 08/01/2007 | CN101007016A Drug for interventional and targeting perfusion therapy of lumbar and cervical disc protrusion and its proportion |
| 08/01/2007 | CN101007015A Application of flavonoids of celery seed and coumarins in preparation of drug for preventing and treating gout |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |